<DOC>
	<DOC>NCT01252888</DOC>
	<brief_summary>The purpose of this study is to assess efficacy and safety of two iStents for the reduction of intraocular pressure associated with primary open-angle glaucoma.</brief_summary>
	<brief_title>Prospective Evaluation of Open-angle Glaucoma Subjects on Two Topical Hypotensive Medication Treated With Two iStents</brief_title>
	<detailed_description>This study evaluates the safety and efficacy of two iStents implanted in primary open-angle glaucoma subjects.</detailed_description>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Glaucoma, Open-Angle</mesh_term>
	<mesh_term>Antihypertensive Agents</mesh_term>
	<criteria>Diagnosed with primary openangle glaucoma (POAG) Subjects on two topical hypotensive medications Traumatic, uveitic, neovascular, or angle closure glaucoma Fellow eye already enrolled</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Open angle</keyword>
	<keyword>Glaucoma</keyword>
	<keyword>Surgery</keyword>
	<keyword>Glaucoma Open-Angle</keyword>
	<keyword>Ocular Hypertension</keyword>
	<keyword>Eye Diseases</keyword>
</DOC>